Co-Authors
This is a "connection" page, showing publications co-authored by Mike Stedman and Adrian Heald.
Connection Strength
8.280
-
"Not Wars, Water pumps"-From emotive to rational language in managing the Covid-19 pandemic. Int J Clin Pract. 2020 10; 74(10):e13580.
Score: 0.895
-
COVID-19: Generate and apply local modelled transmission and morbidity effects to provide an estimate of the variation in overall relative healthcare resource impact at general practice granularity. Int J Clin Pract. 2020 Sep; 74(9):e13533.
Score: 0.889
-
A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis. Int J Clin Pract. 2020 Aug; 74(8):e13528.
Score: 0.883
-
Demographic factor clustering at a GP practice level in England and its relation to glycaemic outcomes: What we can learn from this. Int J Clin Pract. 2019 05; 73(5):e13303.
Score: 0.821
-
Real-world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes. Int J Clin Pract. 2018 Dec; 72(12):e13252.
Score: 0.784
-
Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England. Diabetes Obes Metab. 2018 07; 20(7):1659-1669.
Score: 0.764
-
The pattern of prescribing of glucose modulating agents for type 2 diabetes in general practices in England 2016/17. Int J Clin Pract. 2018 Apr; 72(4):e13080.
Score: 0.759
-
Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication. Int J Clin Pract. 2021 Dec; 75(12):e14714.
Score: 0.243
-
Analysis of Continuous Blood Glucose Data in People with Type 1 Diabetes (T1DM) After COVID-19 Vaccination Indicates a Possible Link Between the Immune and the Metabolic Response. J Diabetes Sci Technol. 2021 09; 15(5):1204-1205.
Score: 0.240
-
How fast should social restrictions be eased in England as COVID-19 vaccinations are rolled out? Int J Clin Pract. 2021 Jul; 75(7):e14191.
Score: 0.236
-
Modelling the impact of the mandatory use of face coverings on public transport and in retail outlets in the UK on COVID-19-related infections, hospital admissions and mortality. Int J Clin Pract. 2021 Mar; 75(3):e13768.
Score: 0.229
-
"Stay at Home, Protect the National Health Service, Save Lives": A cost benefit analysis of the lockdown in the United Kingdom. Int J Clin Pract. 2021 Mar; 75(3):e13674.
Score: 0.226
-
Personal protective equipment (PPE) and infection among healthcare workers - What is the evidence? Int J Clin Pract. 2020 Nov; 74(11):e13617.
Score: 0.225
-
Patient perception of support within primary care is as important as medication and services in achieving good glycaemic control. Int J Clin Pract. 2019 07; 73(7):e13356.
Score: 0.208
-
Quantifying the link between long-term condition (LTC) patient experience in primary care and their clinical outcomes as measured by the National Diabetes Audit. Int J Clin Pract. 2018 10; 72(10):e13255.
Score: 0.197
-
Long-term conditions and the National Diabetes Audit. Br J Gen Pract. 2018 07; 68(672):320.
Score: 0.194
-
Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit. Diabet Med. 2018 01; 35(1):63-71.
Score: 0.187
-
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit. Diabetes Obes Metab. 2018 01; 20(1):185-194.
Score: 0.183
-
Age of people with type 2 diabetes and the risk of dying following SARS-CoV-2 infection. Int J Clin Pract. 2021 Aug; 75(8):e14053.
Score: 0.060
-
Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management. Int J Clin Pract. 2021 04; 75(4):e13980.
Score: 0.059